Abstract:Abstract Epigenetic regulation in conjunction with signaling pathways, play crucial roles in pluripotency, cell differentiation, and transcriptional plasticity in cancer. Indeed, a third of all cancers aberrantly express pluripotency genes and retain stemness, allowing for cancer recurrence following chemo- or radiotherapy. Vascular Endothelial Zinc Finger 1 (VEZF1) is a transcription factor expressed ubiquitously in adult tissues. VEZF1 null ESCs retain alkaline phosphatase staining postdifferentiation, suggesting a potential role of VEZF1 in pluripotency exit. However, the role of VEZF1 in pluripotency maintenance and exit is novel. Using mouse embryonic stem cells as a model system for pluripotency maintenance and exit, we sought to determine the regulatory role of VEZF1 in pluripotency. Our data indicate that ESCs derived from Vezf1 knockout mice (Vezf1 KO) show higher expression of pluripotency genes than Wildtype (WT) cells. Increased expression of pluripotency genes was confirmed upon the temporal ablation of Vezf1 in ESCs using a Doxycycline-inducible knockdown system. Interestingly, we observed that Vezf1 KO ESCs show severe defects in the repression of the pluripotency program postdifferentiation. Our analysis of VEZF1 ChIP-Seq data in ESCs revealed the binding of VEZF1 to promoters of multiple genes involved in canonical WNT and MAPK signaling. The WNT and MAPK signaling pathways are crucial for pluripotency maintenance and exit. Therefore, we proposed that VEZF1 enhances the inducible expression of WNT signaling genes in normal and cancer cells. To test this hypothesis, we performed RNA-Seq analysis which showed decreased expression of WNT signaling genes in Vezf1 KO ESCs, supporting the role of VEZF1 in Wnt signaling. Previous data indicate a significant overlap of VEZF1 and CTCF genome-wide. Therefore, to gain insights into the mechanism of gene regulation by VEZF1, we performed CTCF ChIP-Seq in WT and Vezf1 null cells. Our data revealed an increase in CTCF binding in the absence of VEZF1 compared to WT cells. The unique CTCF binding profile in Vezf1 KO cells was associated with genes involved in WNT and MAPK signaling pathways, both of which regulate pluripotency. This observation suggests that Vezf1 occludes CTCF from repressing WNT signaling genes. Our study of VEZF1 in ESCs suggests that the reduced expression of Vezf1 in cancer cells will potentially support the formation of cancer stem cells. Indeed, we have observed reduced expression of Vezf1 in F9 embryonal carcinoma cells (ECCs). Notably, F9 ECCs exhibit incomplete repression of pluripotency genes akin to Vezf1 KO ESCs. Collectively, this novel study emphasizes the importance of VEZF1 in regulating pluripotency and will expand our understanding of the development of stemness in cancer cells toward developing effective therapeutics against cancer. Citation Format: Isaiah K. Mensah, Martin Emerson, Hern Tan, Ming He, Humaira Gowher. Vascular endothelial zinc finger 1 promotes stemness by regulating key signaling pathways [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 329.

TCF3 Inhibits F9 Embryonal Carcinoma Growth by the Down-Regulation of Oct4.

Transcription factor 3 promotes migration and invasion potential and maintains cancer stemness by activating ID1 expression in esophageal squamous cell carcinoma.

TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer

The Emerging Roles of Oct4 in Tumor-Initiating Cells.

Tbl1 promotes Wnt/β-catenin signaling-induced degradation of the Tcf7l1 protein in mouse ESCs

Overexpression of transcription factor 3 drives hepatocarcinoma development by enhancing cell proliferation via activating Wnt signaling pathway

Impacts of TP53TG1 in cancer-associated fibroblasts-derived exosomes on epithelial-mesenchymal transition capacity of colorectal carcinoma cells by targeting miR-330-3p

TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior in vivo and in vitro

TFEB and TFE3 Depletion Increases Cancer Stem Cell Characteristics and EMT in Triple‐Negative Breast Cancer

TCF3 as a multidimensional biomarker: oncogenicity, genomic alterations, and immune landscape in pan-cancer analysis

TCF7L1 suppresses primitive streak gene expression to support human embryonic stem cell pluripotency

TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9

TGFBR3 inhibits progression of papillary thyroid cancer by inhibiting the PI3K/AKT pathway and EMT

MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM3

TCF3 Regulates the Proliferation and Apoptosis of Human Spermatogonial Stem Cells by Targeting PODXL

Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.

Expression and Splice Variant Analysis of Human TCF4 Transcription Factor in Esophageal Cancer

Abstract 329: Vascular endothelial zinc finger 1 promotes stemness by regulating key signaling pathways

FOXN3: A Novel Tumor Suppressor Inhibits the Progression of Esophageal Cancer via Downregulating the SIRT1/PI3K/AKT Axis

TGFBR3 inhibits progression of papillary thyroid cancer by inhibiting PI3K/AKT pathway and EMT

Mir‑378a‑3p Exerts Tumor Suppressive Function on the Tumorigenesis of Esophageal Squamous Cell Carcinoma by Targeting Rab10.